Ca2+ sequestration as a determinant of chaos and mixed-mode dynamics in agonist-induced vasomotion

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 272, Issue 4 41-4, 1997, Pages

  Griffith, T M ^a   Edwards, D H ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

charybdotoxin; cyclopiazonic acid; ouabain; ryanodine; sarcoplasmic reticulum; thapsigargin

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM ION; CHARYBDOTOXIN; CYCLOPIAZONIC ACID; HISTAMINE; OUABAIN; POTASSIUM ION; RYANODINE; THAPSIGARGIN; VERAPAMIL; ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM; ENZYME INHIBITOR; INDOLE DERIVATIVE; N(G) NITROARGININE METHYL ESTER;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL REACTIVITY; CALCIUM TRANSPORT; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RESISTANCE BLOOD VESSEL; SMOOTH MUSCLE FIBER; TRANSPORT KINETICS; ANIMAL; ARTERY; BIOLOGICAL MODEL; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; EAR; IN VITRO STUDY; METABOLISM; NONLINEAR SYSTEM; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; VASOCONSTRICTION; VASODILATATION;

ANIMALS; ARTERIES; CALCIUM; CALCIUM-TRANSPORTING ATPASES; CHARYBDOTOXIN; EAR; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HISTAMINE; INDOLES; MALE; MODELS, CARDIOVASCULAR; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NONLINEAR DYNAMICS; OUABAIN; RABBITS; RYANODINE; THAPSIGARGIN; VASOCONSTRICTION; VASODILATION; VERAPAMIL;

EID: 33745362341     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.272.4.h1696     Document Type: Article

References (18)

1. 3H] ouabain binding in rat resistance vessels. J. Physiol. (Lond.) 362: 215-231, 1985.
2. Berridge, M. J. Inositol phosphate and calcium signalling. Nature 361: 315-325, 1993.
3. 3- and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature 351: 751-754, 1991.
4. Clapham, D. E. Replenishing the stores. Nature 375: 634-635, 1995.
5. Darby, P. J., C.-Y. Kwan, and E. E. Daniel. Use of calcium pump inhibitors in the study of calcium regulation in smooth muscle. Biol. Signals 2: 293-304, 1993.
6. i oscillations in T lymphocytes. J. Gen. Physiol. 103: 365-388, 1994.
7. 2+ concentration oscillations in thapsigargin-treated parotid acinar cells are caffeine- and ryanodine-sensitive. J. Biol. Chem. 22: 14535-14538, 1991.
8. Fukao, M., Y. Hattori, M. Kanno, I. Sakuma, and A. Kitabatake. Thapsigargin- and cyclopiazonic acid-induced endothelium-dependent hyperpolarization in rat mesenteric artery. Br. J. Pharmacol. 115: 987-992, 1995.
9. Ghosh, T. K., J. M. Mullaney, F. I. Tarazi, and D. L. Gill. GTP-activated communication between distinct inositol 1,4,5-phosphate-sensitive and -insensitive calcium pools. Nature 340: 236-239, 1989.
10. 2+ oscillations and for their frequency encoding through protein phosphorylation. Proc. Natl. Acad. Sci. USA 87: 1461-1465, 1990.
11. 2+ pump blockers: thapsigargin and cyclopiazonic acid. Eur. J. Physiol. 429: 617-624, 1995.
12. Grassberger, P., and I. Procaccia. Measuring the strangeness of strange attractors. Physica D 9: 189-208, 1983.
13. Griffith, T. M. Temporal chaos in the microcirculation. Cardiovasc. Res. 31: 342-358, 1996.
14. Griffith, T. M., and D. H. Edwards. EDRF suppresses chaotic pressure oscillations in isolated resistance artery without influencing intrinsic complexity. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H1786-H1800, 1994.
15. 2+ fluxes in genesis of chaotic arterial pressure oscillations Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H1801-H1811, 1994.
16. Griffith, T. M., and D. H. Edwards. Complexity of chaotic vasomotion is insensitive to flow and pressure but can be regulated by external control. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H656-H668, 1995.
17. Iino, M. Calcium release mechanisms in smooth muscle. Jpn. J. Pharmacol. 54: 345-354, 1990.
18. Kwan, C. Y., R. Chaudhary, X. F. Zheng, J. Ni, and R. M. Lee. Effects of sarcoplasmic reticulum calcium pump inhibitors on vascular smooth muscle. Hypertension 23, Suppl.: I-156-I-160, 1994.